HAZEN SAMUEL N
CEO
HAZEN SAMUEL N has filed 5 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Feb 12, 2026.
On the most recent filing, HAZEN SAMUEL N is listed as CEO at HCA Healthcare, Inc. Inside the rolling window, HAZEN SAMUEL N reported no open-market purchases and 1 open-market sale totaling $21.5M in HCA.
Companies traded
Other insiders at HCA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HAZEN SAMUEL N made?
HAZEN SAMUEL N has filed 5 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does HAZEN SAMUEL N trade?
HAZEN SAMUEL N has filed SEC Form 4 disclosures for 1 company, including HCA.
When was HAZEN SAMUEL N's most recent SEC Form 4 filing?
HAZEN SAMUEL N's most recent SEC Form 4 filing on Tracefour is dated Feb 12, 2026.
What is HAZEN SAMUEL N's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, HAZEN SAMUEL N is listed as CEO.
What is HAZEN SAMUEL N's total buy and sell value in the current window?
Inside the rolling retention window, HAZEN SAMUEL N bought $0 and sold $21.5M based on SEC Form 4 filings.
What was HAZEN SAMUEL N's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 42,877 HCA shares on 2026-02-03, worth $21.5M, per SEC Form 4 filings.